Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a …

D Capodanno, AS Petronio, B Prendergast… - European heart …, 2017 - academic.oup.com
Despite continuing efforts during the last decades, there is no 'ideal prosthetic valve
substitute'. Every valve prosthesis invokes new pathophysiological processes, including the …

Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials

GCM Siontis, F Praz, T Pilgrim, D Mavridis… - European heart …, 2016 - academic.oup.com
Aims In view of the currently available evidence from randomized trials, we aimed to
compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) …

Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel

J Rodés-Cabau, KA Ellenbogen, AD Krahn… - Journal of the American …, 2019 - jacc.org
Despite major improvements in transcatheter aortic valve replacement (TAVR)
periprocedural complications in recent years, the occurrence of conduction disturbances has …

2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European …

H Baumgartner, J De Backer… - European heart …, 2021 - academic.oup.com
Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

[HTML][HTML] Surgical or transcatheter aortic-valve replacement in intermediate-risk patients

MJ Reardon, NM Van Mieghem… - New England journal …, 2017 - Mass Medical Soc
Background Although transcatheter aortic-valve replacement (TAVR) is an accepted
alternative to surgery in patients with severe aortic stenosis who are at high surgical risk …

Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical …

HGH Thyregod, DA Steinbrüchel, N Ihlemann… - Journal of the American …, 2015 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …

[HTML][HTML] Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke

L Søndergaard, SE Kasner, JF Rhodes… - … England Journal of …, 2017 - Mass Medical Soc
Background The efficacy of closure of a patent foramen ovale (PFO) in the prevention of
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …

[HTML][HTML] Possible subclinical leaflet thrombosis in bioprosthetic aortic valves

RR Makkar, G Fontana, H Jilaihawi… - … England Journal of …, 2015 - Mass Medical Soc
Background A finding of reduced aortic-valve leaflet motion was noted on computed
tomography (CT) in a patient who had a stroke after transcatheter aortic-valve replacement …

Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study

T Chakravarty, L Søndergaard, J Friedman… - The Lancet, 2017 - thelancet.com
Background Subclinical leaflet thrombosis of bioprosthetic aortic valves after transcatheter
valve replacement (TAVR) and surgical aortic valve replacement (SAVR) has been found …

[HTML][HTML] A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

GD Dangas, JGP Tijssen, J Wöhrle… - New England journal …, 2020 - Mass Medical Soc
Background Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic
events after transcatheter aortic-valve replacement (TAVR) is unclear. Methods We …